There were 1,710 press releases posted in the last 24 hours and 358,926 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Theratechnologies reçoit de la FDA la date cible d’approbation de mars 2025 à la licence de produit biologique mise à jour pour la formulation F8 de la tésamoréline

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image